Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Effect of Celery Extract on Thyroid Function; Is Herbal Therapy Safe in Obesity?

Maljaei MB, Moosavian SP, Mirmosayyeb O, Rouhani MH, Namjoo I, Bahreini A.

Int J Prev Med. 2019 May 6;10:55. doi: 10.4103/ijpvm.IJPVM_209_17. eCollection 2019.

2.

SNAIL is induced by tamoxifen and leads to growth inhibition in invasive lobular breast carcinoma.

Bossart EA, Tasdemir N, Sikora MJ, Bahreini A, Levine KM, Chen J, Basudan A, Jacobsen BM, Burns TF, Oesterreich S.

Breast Cancer Res Treat. 2019 Jun;175(2):327-337. doi: 10.1007/s10549-019-05161-8. Epub 2019 Feb 23.

PMID:
30798422
3.

Targeted mutation detection in breast cancer using MammaSeqâ„¢.

Smith NG, Gyanchandani R, Shah OS, Gurda GT, Lucas PC, Hartmaier RJ, Brufsky AM, Puhalla S, Bahreini A, Kota K, Wald AI, Nikiforov YE, Nikiforova MN, Oesterreich S, Lee AV.

Breast Cancer Res. 2019 Feb 8;21(1):22. doi: 10.1186/s13058-019-1102-7.

4.

Ameliorating effect of encapsulated hepatocyte-like cells derived from umbilical cord in high mannuronic alginate scaffolds on acute liver failure in rats.

Varaa N, Azandeh S, Khorsandi L, Bijan Nejad D, Bayati V, Bahreini A.

Iran J Basic Med Sci. 2018 Sep;21(9):928-935. doi: 10.22038/IJBMS.2018.27928.6847.

5.

The Comparison of the Effect of Mannitol and N Acetyl Cysteine on Liver Function in Partial Hepatectomy.

Janatmakan F, Javaherforoosh Zadeh F, Alizadeh M, Alizadeh Z, Bahreini A.

Anesth Pain Med. 2018 Sep 22;8(5):e79677. doi: 10.5812/aapm.79677. eCollection 2018 Oct.

6.

Frequent ESR1 and CDK Pathway Copy-Number Alterations in Metastatic Breast Cancer.

Basudan A, Priedigkeit N, Hartmaier RJ, Sokol ES, Bahreini A, Watters RJ, Boisen MM, Bhargava R, Weiss KR, Karsten MM, Denkert C, Blohmer JU, Leone JP, Hamilton RL, Brufsky AM, Elishaev E, Lucas PC, Lee AV, Oesterreich S.

Mol Cancer Res. 2019 Feb;17(2):457-468. doi: 10.1158/1541-7786.MCR-18-0946. Epub 2018 Oct 24.

PMID:
30355675
7.

Recurrent hyperactive ESR1 fusion proteins in endocrine therapy-resistant breast cancer.

Hartmaier RJ, Trabucco SE, Priedigkeit N, Chung JH, Parachoniak CA, Vanden Borre P, Morley S, Rosenzweig M, Gay LM, Goldberg ME, Suh J, Ali SM, Ross J, Leyland-Jones B, Young B, Williams C, Park B, Tsai M, Haley B, Peguero J, Callahan RD, Sachelarie I, Cho J, Atkinson JM, Bahreini A, Nagle AM, Puhalla SL, Watters RJ, Erdogan-Yildirim Z, Cao L, Oesterreich S, Mathew A, Lucas PC, Davidson NE, Brufsky AM, Frampton GM, Stephens PJ, Chmielecki J, Lee AV.

Ann Oncol. 2018 Apr 1;29(4):872-880. doi: 10.1093/annonc/mdy025.

8.

Clinically Observed Estrogen Receptor Alpha Mutations within the Ligand-Binding Domain Confer Distinguishable Phenotypes.

Jia S, Miedel MT, Ngo M, Hessenius R, Chen N, Wang P, Bahreini A, Li Z, Ding Z, Shun TY, Zuckerman DM, Taylor DL, Puhalla SL, Lee AV, Oesterreich S, Stern AM.

Oncology. 2018;94(3):176-189. doi: 10.1159/000485510. Epub 2018 Jan 6.

9.

Upregulation of IRS1 Enhances IGF1 Response in Y537S and D538G ESR1 Mutant Breast Cancer Cells.

Li Z, Levine KM, Bahreini A, Wang P, Chu D, Park BH, Oesterreich S, Lee AV.

Endocrinology. 2018 Jan 1;159(1):285-296. doi: 10.1210/en.2017-00693.

10.

Associating liver partition and portal vein ligation for staged hepatectomy: A surgical technique for liver resections.

Sanei B, Sheikhbahaei S, Sanei MH, Bahreini A, Jafari HR.

J Res Med Sci. 2017 Apr 26;22:52. doi: 10.4103/jrms.JRMS_829_16. eCollection 2017.

11.

Mutation site and context dependent effects of ESR1 mutation in genome-edited breast cancer cell models.

Bahreini A, Li Z, Wang P, Levine KM, Tasdemir N, Cao L, Weir HM, Puhalla SL, Davidson NE, Stern AM, Chu D, Park BH, Lee AV, Oesterreich S.

Breast Cancer Res. 2017 May 23;19(1):60. doi: 10.1186/s13058-017-0851-4.

12.

Non-coding single nucleotide variants affecting estrogen receptor binding and activity.

Bahreini A, Levine K, Santana-Santos L, Benos PV, Wang P, Andersen C, Oesterreich S, Lee AV.

Genome Med. 2016 Dec 13;8(1):128.

13.

Study of the Vitamin D Levels in Patients Referred to Clinical Laboratories in Mashhad in 2015 and their Relationship with the Patients' Lipid Profiles.

Shamsian AA, Rezaee SA, Rajabiian M, Moghaddam HT, Saeidi M, Bahreini A.

Electron Physician. 2016 Apr 25;8(4):2269-73. doi: 10.19082/2269. eCollection 2016 Apr.

14.

Effect of Topical Estrogen in the Mangement of Traumatic Facial Wounds.

Ghazizadeh Hashemi SA, Barati B, Mohammadi H, Saeidi M, Bahreini A, Kiani MA.

Iran J Otorhinolaryngol. 2016 Jan;28(84):45-9.

15.

Five Years Survival of Patients After Liver Transplantation and Its Effective Factors by Neural Network and Cox Poroportional Hazard Regression Models.

Khosravi B, Pourahmad S, Bahreini A, Nikeghbalian S, Mehrdad G.

Hepat Mon. 2015 Sep 1;15(9):e25164. doi: 10.5812/hepatmon.25164. eCollection 2015 Sep.

16.

Sensitive Detection of Mono- and Polyclonal ESR1 Mutations in Primary Tumors, Metastatic Lesions, and Cell-Free DNA of Breast Cancer Patients.

Wang P, Bahreini A, Gyanchandani R, Lucas PC, Hartmaier RJ, Watters RJ, Jonnalagadda AR, Trejo Bittar HE, Berg A, Hamilton RL, Kurland BF, Weiss KR, Mathew A, Leone JP, Davidson NE, Nikiforova MN, Brufsky AM, Ambros TF, Stern AM, Puhalla SL, Lee AV, Oesterreich S.

Clin Cancer Res. 2016 Mar 1;22(5):1130-7. doi: 10.1158/1078-0432.CCR-15-1534. Epub 2015 Oct 23.

17.

Differentiation of adipose-derived stem cells into Schwann-like cells: fetal bovine serum or human serum?

Younesi E, Bayati V, Hashemitabar M, Azandeh SS, Bijannejad D, Bahreini A.

Anat Cell Biol. 2015 Sep;48(3):170-6. doi: 10.5115/acb.2015.48.3.170. Epub 2015 Sep 22.

18.

Effects of N-Acetylcysteine Addition to University of Wisconsin Solution on the Rate of Ischemia-Reperfusion Injury in Adult Orthotopic Liver Transplant.

Aliakbarian M, Nikeghbalian S, Ghaffaripour S, Bahreini A, Shafiee M, Rashidi M, Rajabnejad Y.

Exp Clin Transplant. 2017 Aug;15(4):432-436. doi: 10.6002/ect.2014.0263. Epub 2015 Jun 25.

19.

En-bloc liver-pancreas transplant in Iran.

Nikeghbalian S, Mehdi SH, Aliakbarian M, Kazemi K, Shamsaeefar A, Bahreini A, Gholami S, Malekhosseini SA.

Arch Iran Med. 2014 Sep;17(9):640-1. doi: 0141709/AIM.0012.

20.

Ex-vivo Resection and Small-Bowel Auto-transplantation for the Treatment of Tumors at the Root of the Mesentery.

Nikeghbalian S, Aliakbarian M, Kazemi K, Shamsaeefar AR, Mehdi SH, Bahreini A, Malek-Hosseini SA.

Int J Organ Transplant Med. 2014;5(3):120-4.

21.

Multivisceral and small bowel transplantation at shiraz organ transplant center.

Nikeghbalian S, Mehdi SH, Aliakbarian M, Kazemi K, Shamsaeefar A, Bahreini A, Mansoorian MR, Malekhosseini SA.

Int J Organ Transplant Med. 2014;5(2):59-65.

22.

De novo malignancy after liver transplant.

Sanaei AK, Aliakbarian M, Kazemi K, Nikeghbalian S, Shamsaeefar A, Mehdi SH, Bahreini A, Dehghani SM, Geramizadeh B, Malekhosseini SA.

Exp Clin Transplant. 2015 Apr;13(2):163-6. doi: 10.6002/ect.2013.0135. Epub 2014 May 19.

23.

Invasive lobular carcinoma cell lines are characterized by unique estrogen-mediated gene expression patterns and altered tamoxifen response.

Sikora MJ, Cooper KL, Bahreini A, Luthra S, Wang G, Chandran UR, Davidson NE, Dabbs DJ, Welm AL, Oesterreich S.

Cancer Res. 2014 Mar 1;74(5):1463-74. doi: 10.1158/0008-5472.CAN-13-2779. Epub 2014 Jan 14.

24.

Multivisceral transplantation for the treatment of intra-abdominal tumors.

Nikeghbalian S, Aliakbarian M, Shamsaeefar A, Kazemi K, Bahreini A, Malekhosseini SA.

Transplant Proc. 2013;45(10):3528-30. doi: 10.1016/j.transproceed.2013.09.002.

PMID:
24314950
25.

Clinical experience in organ transplant from the Shiraz Transplant Center: 2011.

Nikeghbalian S, Aliakbarian M, Kazemi K, Shamsaee far A, Salehipour M, Bahreini A, Mehdi SH, Salahi H, Bahador A, Malekhossein SA.

Exp Clin Transplant. 2012 Aug;10(4):307-9.

26.

En-bloc Transplantation: an Eligible Technique for Unilateral Dual Kidney Transplantation.

Salehipour M, Bahador A, Nikeghbalian S, Kazemi K, Shamsaeifar AR, Ghaffaripour S, Sahmeddini MA, Salahi H, Bahreini A, Janghorban P, Gholami S, Malek-Hosseini SA.

Int J Organ Transplant Med. 2012;3(3):111-4.

Supplemental Content

Loading ...
Support Center